2002 US-China Conference on Science, Technology, Business and Entrepreneurship and CAST-USA 10-Year Anniversary
2002年美中科技、商贸、和创业大會
Uris Hall, 3022 Broadway at 117th Street, Business School of Columbia University, New York, November 16
Chair: Dr. Zhenghui Zhang, New York University
Co-Chair: Dr. Nan Yao, Princeton University
Organizer: Dr. Dongguang Wei, New Jersey Institute of Technology
Host: Chinese Association for Science & Technology, USA
Co-organized by
CAST Bio-Tech and Pharmaceutical Society
10:40-12:10, November 15, 2002
Session BT-1: Nano-materials and Fabrication I
Chair: Dr. Nan Yao, Princeton University
1. Ganesh Skandan, Nanopowder Enterprises Incorporated, “Tailored Nanomaterials for Functional and Structural Applications,”
2. Prof. Yen Wei, Drexel University, "Nanostructured and Functional Materials for Cardiovascular and Neuronal Tissue Engineering".
3. Prof. Rajesh Dave, New Jersey Institute of Technology, "Research on Engineered Particulates at NJIT".
2:00-3:30pm, November 15, 2002
Chair: Dr. Jianjun Luo, New Jersey Center for Engineered Particulates
4. Dr. J.J. Luo, New Jersey Institute of Technology, "Supercritical Fluid Processing Technology---a Promise for Designing Nanostructure in Pharmaceutical Industry"
5. Dr. Nan Yao, Princeton University, "Microscopy of Nanostructured Materials".
6. Prof. Huixin He, Rutgers University, “From Nanowires to Nanogaps for Molecular Devices”.
3:45-5:45, November 15, 2002
Session BT-3: The Present, Business Opportunities, and Challenge in Sino-America Biotechnology & Pharmaceutical Field
Chair: Dr. Wenlin Huang, Ph.D.
President for CAST-Biotech/Pharmaceutical Society
Chief Scientific Officer of Shenzhen Bio-port Investment Company
Co-Chair: Dr. Li Yin, M.D., Ph.D.
Deputy Director of Social Development Bureau of the State Council Research Office, P.R. China.
Organizer: Dr. Hui Zhou, M.D., Ph.D.
Secretary General for CAST-Biotech/Pharmaceutical Society
Research Associate at Rockefeller University
7. Dr. Ergang Shi, Ph.D., Senior Scientist of Protein Science Department of Regeneron Pharmaceutical Inc.
“Emerging Proteomic-Based Biopharmaceutical Industry and Its Economic Impact”
8. Mr. Keming Wu, M.S., Deputy Mayer of Wuhu Municipal Government
“A Brief Introduction of the Development of Biotechnology and Pharmaceuticals in China”
9. Dr. Jialun, M.D., Ph.D., President & CEO for GenoPharm Inc.
“Current Study for Stem Cell Differentiation and Future Clinical Application”
10. Dr. Jianqiang Zou, Principal Investigator of “Modernizing Chinese Traditional Medicine” Program in Ministry of Science and Technology of P. R. China
“Modernization of Chinese Traditional Medicine in China”
11. Dr. Tailiang Xie, Ph.D., Assistant Director in Biostatistics Clinical and Medical Affairs of Wyeth “The Biotechnology & Pharmaceutical Industries in USA and FDA Regulation”
10:15-12:15, November 16, 2002
Session BT-4: Bio-tech and New Medicine Development I
Chair: Dr. Hock S. Tan, Principal Engineer, Johnson & Johnson
12. Dr. Bin Li, Merril Lynch, "Wall Street Perspectives of New Medicine Development."
13. Dr. Mark Tang, World Technology Ventures, LLC, "Top Ten Tips for Bio-entrepreneurs."
14. Dr. Bing Yan, Johnson & Johnson, "Drug Development - Clinical Perspectives."
15. Dr. Dean Wei, President and CEO, ChemPacific, "Advances of Biocatalysis Technology in Chiral API Manufacturing."
2:00-3:30pm, November 16, 2002
Chair: Dr. Mark Tang, Managing Director, World Technology Ventures, LLC
16. Prof. Min Lu, Cornell University, "HIV-1 Entry and Its Inhibition."
17. Dr. Xiaoming Zou, Amgen Inc., "Mononclonal Antibody Drug Development: Opportunities & Challenges."
18. Dr. Xuemin Ye, NY State Inst for Basic Research, "Current Development of Traditional Chinese Medicine."